A call by regulators to stop J&J vaccinations won't dramatically disrupt supply in the U.S. But changes in labeling are possible, as is a renewed debate over vaccine hesitancy.
Original source: https://www.healthcaredive.com/news/johnson-johnson-vaccine-pause-supply-acip-hesitancy/598368/